Skip to main content
News Icon

News categories: Publication

Macrophages in the maintenance of the enteric nervous system

Loss of nerve cells is a process that can take place not only in the brain, but also in the (less well-known) nervous system in the gut. A new study, lead by the KU Leuven under contribution of ImmunoSensation² member Prof. Andreas Schlitzer of the LIMES Institute at Bonn University shows that specialised immune cells shape this nervous system, enabling the gut to make the transition to solid food early in life. At a later stage, these immune cells take on another role – they start protecting and maintaining the nerve cells. The findings have now been published in Nature.

Macrophages, play a crucial role in the nervous system in the gut. This is shown by a team of researchers,lead by gastroenterologist Guy Boeckxstaens of KU Leuven. Research in mice shows that the proper functioning of macrophages is crucial for the organisation of nerve cells into a network just after birth, and later for their maintenance in accordance with proper digestion.

“Indeed, we see that macrophages can perform several functions in line with the specific requirements of the nerve cells,” Professor Boeckxstaens explains. "In the first phase of life, they take care of maturing the nervous system: the macrophages eat, as it were, the redundant nerve cells and provide the right structure. This is necessary for the transition from liquid to solid food. Once this maturation is complete, the nerve cells send a signal to the macrophages, using the molecule TGF-ß, with the instruction to no longer to eat the nerve cells, but instead to start nurturing them."

Until now, it had been unclear what mechanisms caused the nervous system in the gut to 'mature' after birth and enable the gut to process solid food. Some infants need more time to tolerate solid food and be able to process it. This could well be down to delayed action by this specific population of macrophages.

Unexplored territory

The research shows the importance of proper interaction between the immune system and the nervous system of the gut. Thus, the perfect interaction between nerve cells and macrophages is fundamental to ensurethe health of the guts nervous system and digestion. If the immune cells do not function well, or too well, the quantity of nerve cells and – by consequence – the function of the gut will be affected too, with delayed gastric motor activity and constipation or diarrhoea as a result. These symptoms are characteristic for the loss of nerve cells in the gut in diseases such as diabetes, or in obesity and old age. A disrupted interaction between macrophages and nerve cells may well play a role in this.

The interaction between the nervous system and the immune system in the gut, and how this may give rise to abnormal gut function and certain health problems, remains a relatively new area of research. “At present, we are still working apace to identify the basic mechanisms for the loss of nerve cells – also known as neurodegeneration – in the gut,” says Guy Boeckxstaens. “Hopefully, we'll be able to track down some new targets for monitoring this process over time that way. And who knows? This gut research might also give us some new insights into what goes wrong with neurodegenerative conditions in the brain, in which similar macrophages also play a major role. We don't call the nervous system of the gut the 'little brain' for no reason.”


Publication

Maria Francesca Viola, et.al., (2023), Dedicated macrophages organize and maintain the enteric nervous system, Nature, June 2023, doi: https://doi.org/10.1038/s41586-023-06200-7

Related news

News Icon

News categories: Publication

Twin Lancet Publications Highlight Promising New Approach for Lupus Treatment

A team of international researchers, including ImmunoSensation³ member Prof. Jörg Wenzel, reports promising phase 2 results for enpatoran, a first-in-class oral TLR7/8 inhibitor, in patients with cutaneous and systemic lupus erythematosus (CLE/SLE). In the WILLOW trial, enpatoran significantly improved skin disease activity in a dose-dependent manner and showed favourable safety outcomes. In systemic SLE, treatment also reduced global disease activity and rapidly suppressed the type I interferon gene signature. The twin studies were published in The Lancet and The Lancet Rheumatology.
View entry
Wissenschaftler

News categories: Publication

Driver of inflammation after mild head injury

Mild traumatic brain injuries can lead to persistent memory problems and an increased risk of dementia. Yet, effective therapies to counteract these long-term consequences are still lacking. Dr. Dr. Sergio Castro-Gomez, Early Career Research Group Leader at the Institute of Physiology II of the University Hospital Bonn has discovered together with colleagues that the ASC protein. The research team hopes to identify new targets for future therapeutic strategies. The study, published in the Journal of Clinical Investigation, lays the foundation for upcoming clinical trials.
View entry
PM Immunity Nebeling

News categories: Publication

Study reveals dynamic interactions between brain tumors and immune cells

Glioblastoma, the most common and aggressive brain tumor in adults, is difficult to treat because this cancer can invade the surrounding brain tissue and spread far beyond the original tumor mass. Researchers from the DZNE, the University Hospital Bonn (UKB), and ImmunoSensation³ at the University of Bonn have observed this infiltration process in the living brain using high-tech microscopy. Their study is based on research in mice with a form of brain tumor that closely resembles human glioblastoma.
View entry

Back to the news overview